| Characterizing the immune responses of those who survived or succumbed to COVID-19: Can immunological signatures predict outcome? R Sami, F Fathi, N Eskandari, M Ahmadi, R ArefNezhad, H Motedayyen Cytokine 140, 155439, 2021 | 22 | 2021 |
| Effects of the programmed cell death 1 (PDCD1) polymorphisms in susceptibility to systemic lupus erythematosus F Fathi, E Sadeghi, N Lotfi, H Hafezi, M Ahmadi, S Mozafarpoor, ... International journal of immunogenetics 47 (1), 57-64, 2020 | 14 | 2020 |
| Epidemiology of obesity and high blood pressure among school-age children from military families: the largest report from our region B Dormanesh, P Arasteh, R Daryanavard, M Mardani, M Ahmadi, ... BMC pediatrics 23 (1), 1-8, 2023 | 3 | 2023 |
| Current advances in stem cell therapy in the treatment of multiple sclerosis P Zolfaghari Baghbadorani, A Rayati Damavandi, S Moradi, M Ahmadi, ... Reviews in the Neurosciences 34 (6), 613-633, 2023 | 3 | 2023 |
| Predictors and Conversion Rate of Clinically Isolated Syndrome to Clinically Definite Multiple Sclerosis: A Follow-up Study in Patients Living in the Southern Part of Iran … S Izadi, M Ahmadi, M Poursadeghfard 2018 The Authors. This is an open access article under the CC-By-NC license …, 2020 | 1* | 2020 |
| Cohort analysis of 50% lethal area (LA50) and associating factors in burn patients based on quality improvements and health policies R Shahriarirad, R Shekouhi, SS Nabavizadeh, M Zardosht, SMK Tadayon, ... Scientific Reports 13 (1), 19034, 2023 | | 2023 |
| Clinical presentation of clinically isolated syndrome (CIS); a long term follow up study in Iranian patients S Izadi, M Ahmadi, MS Dorche, A Nikseresht MULTIPLE SCLEROSIS JOURNAL 23, 705-705, 2017 | | 2017 |
Farshid FathiIsfahan University of Medical Sciences在 resident.mui.ac.ir 的电子邮件经过验证
